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Abstract - Melanoma is the most deadly form of skin cancer of melanocytic origin. The tumor has a high malignant po-
tential and early metastasis. Prognosis is directly linked to the stage of the disease. Diagnosing thin melanoma at an early 
stage offers patients their best chance for survival. The crucial innovation in the early recognition of melanoma was the 
development of in vivo examination of the skin in high-resolution, by confocal microscopy. Confocal microscopy and its 
modifications provides a “virtual biopsy“, owing to melanosomes and melanin, which are a source of endogenous contrast. 
Confocal scanning laser microscopy (CSLM) provides visualization of microanatomical structures and cellular detail in 
real time (pigmented keratinocytes, melanocytes, melanosomes and melanophages) in the epidermis, dermoepidermal 
junction and superficial dermis at a resolution equivalent to the resolution of conventional microscopes.
Key words: Melanoma, melanocytic skin tumor, laser, dermoscopy, confocal microscopy, in vivo CLSM, sensitivity, speci-
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INTRODUCTION
Melanoma represents an aggressive tumor that ear-
ly metastasizes and is resistant to medical therapy 
(Lazar et al., 2010). In the past several decades, the 
incidence  of  cutaneous  melanoma  has  increased 
more rapidly than any other cancer. This “melanoma 
epidemic”  has  stabilized  over  the  last  decade  and 
has even begun to fall in younger cohorts. The re-
cent trends in incidence may reflect effective public 
education  campaigns  for  primary  prevention  via 
sun protection and avoidance (Schaffer et al., 2004). 
However, the incidence rates continue to increase 
in western, eastern, and southern Europe, particu-
larly in older men and women (De Vries and Coe-
bergh, 2004). Also, the mortality of melanoma has 
increased, showing a consistently higher mortality in 
men than in women (MacKie et al., 2002; De Vries et 
al., 2003; Lindholm et al., 2004). 
Tumor thickness is the most important factor 
in  survival  prognosis.  Early  diagnosis  and  surgi-
cal excision of the primary cutaneous melanoma in 
specialized institutions leads to better surveillance 
(Džodić, 2010). “The timely diagnosis and surgical 
treatment of melanoma are the only approaches to 
date that have increased survival”. This statement in 
the Journal of the American Academy of Dermatol-
ogy by Sober and his coworkers in 1980, unfortu-
nately, still holds true today (Sober, 1980). In the ab-
sence of effective treatment approaches of advanced 
disease, no agent has consistently been shown to 280 MILICA APOSTOLOVIĆ STOJANOVIĆ ET AL.
produce a benefit to overall survival (Schaffer et al., 
2004). 
The ability to recognize the varied clinical “faces” 
of melanoma (including those of thin, “featureless” 
and amelanotic melanoma) continues to evolve and 
improve with each passing day as a result of the im-
plementation of imaging technologies in oncologi-
cal dermatology. The introduction of dermoscopy in 
1989 provided a noninvasive method of visualizing 
subsurface  structures  of  the  epidermis  and  papil-
lary dermis that are not discernible to the naked eye 
(Schaffer et al., 2004). In a recent systematic review of 
the diagnostic accuracy of dermoscopy in detecting 
melanoma, a 10-27% higher sensitivity than clinical 
diagnosis by the naked eye has been reported (Mayer, 
1997). In the predermoscopy era, the ABCD(E) clin-
ical rule and good clinical visual inspection were the 
main diagnostic tool whose sensitivity values ranged 
between 65%-80%, depending on the expertise of 
the clinician (Schaffer et al., 2004; Miller and Acker-
mann 1992; Wolf et al., 1998). After the implementa-
tion of dermoscopy, there was a significant reduction 
in the benign:malignant ratio of excised melanocytic 
lesions from 18:1 to 4:1 (pre- and postdermoscopy 
eras, respectively) (Carli et al., 2004). Dermoscopy is 
a rapidly evolving field and it has become an impor-
tant tool for the diagnosis of skin tumors (Braun et al., 
2009). However, the presence of benign lesions with 
dermoscopic aspects indistinguishable from melano-
ma, melanomas lacking specific dermoscopic and/or 
clinical features, the presence of hypo- or amelanotic 
melanoma also represent great diagnostic challenges 
(Menzies et al., 1998; Menzies et al., 1996; Carli et 
al., 2004; Puig et al., 2007). The existence of so-called 
“featureless” melanoma (unrecognizable both clini-
cally and dermoscopically) varies from 1-15%, and 
definitively implies the need for diagnostic improve-
ment and new preoperative diagnostic tools (Carli et 
al., 2002; Pizzichetta et al., 2004).
In  vivo  confocal  scanning  laser  microscopy 
(CSLM) is a novel technique enabling the noninva-
sive imaging of the skin – the epidermis, papillary 
dermis and upper part of the reticular dermis. In vivo 
CSLM represents the missing link between dermos-
copy and histological examination by producing hor-
izontal sections of the skin with precise correspond-
ence to the dermoscopic feature at cellular-level res-
olution and correspondence to histological findings 
(Rajadhyaksha et al., 1999; Pellacani et al., 2005). The 
application of confocal microscopy and its modifica-
tion provide a “virtual biopsy“, owing to the presence 
of melanosomes and melanin, which are a strong 
source of endogenous contrast. In addition, CSLM 
provides visualization of microanatomical structures 
and cellular detail in real time (pigmented keratinoc-
ytes, melanocytes, melanosomes and melanophages) 
at a resolution that is equivalent to the resolution of 
conventional microscopes (Busam et al., 2001a).
With its reflectance mode, confocal microscopy 
(RCM) can visualize the skin in vivo and in freshly 
biopsied skin without fixing, sectioning, and staining 
(necessary for the preparation of conventional his-
tological slides). The resolution enables the imaging 
of the nuclear, cellular, and tissue architecture of the 
epidermis and the underlying structures, including 
the connective tissue, inflammatory infiltrates, tu-
mor cells, capillaries, and even circulating blood cells 
(Rajadhyaksha et al., 1995).
Historical Development of Confocal Scanning Laser 
Microscopy
Marvin Minsky described the first confocal micro-
scope in 1957 (Minsky, 1957). A tandem scanning 
confocal  microscope  was  designed  by  Petranin  in 
1968 to optically section tissue in real time (Petran 
et al., 1968). Research on in vivo imaging of human 
skin ultrastructure with confocal microscopy began 
in the early 1990s (New et al., 1991 Corcuff and Lev-
eque, 1993, Veiro and Cummins, 1994). Rajadhyak-
sha et al. constructed a laboratory prototype use of a 
laser light source providing high illumination power 
and deeper penetrating wavelengths of near infrared 
to improve imaging capabilities. In 1995, Rajadhyak-
sha et al. first reported the foundations of laser scan-
ning RCM (Rajadhyaksha et al.. 1995). They reported 
the ability to image high-resolution nuclear and cel-
lular level detail in normal human skin in vivo with 
good correlation to conventional histology. In 1999, CONFOCAL MICROSCOPY IN THE DIAGNOSIS OF MELANOMA 281
the same authors reported improved resolution, con-
trast, depth of imaging, and field of view with further 
advances in confocal instrumentation (Rajadhyaksha 
et al., 1999).
Langley  and  colleagues  (2001)  presented  the 
first study of benign and malignant melanocytic le-
sions by in vivo confocal microscopy. Busam et al. 
(2001a)  investigated  the  feasibility  of  recognizing 
the cellular constituents of pigmented skin lesions, 
such as pigmented keratinocytes, melanocytes, and 
melanophages, by CSLM. The same authors, in 2002. 
demonstrated  that  intraepidermal  melanoma  can 
be recognized by CSLM through analysis of the in-
traepidermal growth patterns of melanocytes using 
the same criteria as established for conventional his-
tology (Busam et al., 2002).
Principles of confocal microscopy
A confocal microscope consists of a light source, a 
condenser, an objective lens and a detector. The light 
source, illuminated point, and detector aperture are 
in  optically  conjugated  focal  planes  (i.e.,  confocal 
planes). This configuration allows the collection of 
light from the single in-focus plane and rejection 
of light from all out-of-focus planes (Gonzalez and 
Gilaberte-Calzada,  2008).  The  light  source  illumi-
nates a small three-dimensional spot (voxel) within 
a sample, such as skin, from which reflected light is 
collected to produce a pixel. The illuminated spot is 
then scanned horizontally over a two-dimensional 
grid to obtain a horizontal microscopic section. This 
process is known as “optical sectioning” of the image 
in a series of horizontal planes stacked vertically to 
produce an image pixel by pixel, with an axial thick-
ness of 2-5 µm (Gareau et al., 2008). This property 
enables a confocal microscope to look at a slice in 
the body of a thick semi-transparent sample, where-
as, conventional microscopes visualize all the planes 
contemporarily  (Branzan  et  al.,  2007).The  optical 
section is oriented parallel (i.e. en face) to the skin 
surface in unlike the conventional orthogonal sec-
tions of histopathology that are oriented perpendicu-
lar to the skin surface. The numerical aperture of the 
objective lens determines image resolution, which 
means that there is an inversely proportional rela-
tionship between high-resolution images and small 
apertures  (less  light),  and  low  resolution  through 
larger apertures (more light). Factors affecting the 
depth of penetration of light include the wavelength 
of illumination, power of illumination, reflectivity of 
the superficial layers, and scattering properties of the 
dermis.  Longer  wavelengths  will  penetrate  deeper 
because  of  decreased  light  scatter,  but  the  resolu-
tion decreases as the wavelength increases (Gonzalez 
and Gilaberte-Calzada, 2008). Confocal images are 
resolved in grey scale. White represents total light 
reflected  and  black  represents  no  reflection  at  all 
(Rajadhyaksha et al., 1995). CSLM can be used in ei-
ther reflectance (in the clinical field) or fluorescence 
mode (in research). 
Optical  reflectance  microscopy  relies  on  the 
natural  variations  in  refractive  indices  of  tissue 
microstructures for contrast. In human skin, mela-
nin is the strongest endogenous contrast source for 
confocal imaging, resulting in a bright appearance 
of  basal  keratinocytes  and  melanocytes.  Although 
melanin absorbs in the near-infrared spectrum (700 
to 1064 nm), its high refractive index (1.7) compared 
to the epidermis (near water 1.34) determines a great 
dispersion of reflected light. According to Mie’s the-
ory, more light is reflected when the tissue contains 
structures of a size similar to the wavelength of the 
light source (Vand de Hulst, 1981). Other sources 
include keratin, mitochondria and cytoplasmic or-
ganelles, chromatin in the nuclei, and collagen in the 
dermis (Rajadhyaksha et al., 1995; Rajadhyaksha et 
al., 1999).
A water immersion objective lens is used because 
the refractive index of water (1.33) closely matches 
the 1.34 refractive index of the living epidermis. It 
also  minimizes  spherical  aberrations  and  reduces 
loss of resolution and contrast when imaging deep in 
the skin. Typically, water-based gels are used as the 
immersion media reducing irregularities in refrac-
tion. The numerical aperture of the objective lens de-
termines the axial resolution and the amount of light 
detected (Rajadhyaksha et al., 1995; Rajadhyaksha et 
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Fluorescence confocal microscopy is based on 
the same optical principles as its reflectance coun-
terpart. Fluorescent CSLM achieves contrast by the 
dynamic distribution pattern of the dye emission. 
CSLM in fluorescence mode relies on the differen-
tial distribution of endogenous or exogenous fluo-
rescent molecules (fluorophores or fluorescent dyes 
such as fluorescein, toluidine blue, methylene blue, 
or Yaroslavsky stains) (Yaroslavsky et al., 2007) to 
provide highly specific contrast in tissue (Delaney, 
1994). A laser light source, at an appropriate wave-
length, is used to excite the fluorophore. The excited 
fluorophore emits a fluorescence signal at a longer 
wavelength, which is then detected and displayed in 
gray scale according to the fluorescence intensity. An 
area of great potential for fluorescence imaging is in 
the ability to target specific subcellular structures or 
proteins of interest, depending on the combination 
of wavelength of light and fluorophores used. Some 
of these dyes distribute selectively to specific tissue 
elements (e.g. nucleus, cytoplasm, stroma), and oth-
ers can be chemically or immunologically targeted to 
specific molecular ligands. Recent studies on dual-
mode reflectance and fluorescence confocal scanning 
microscopy in murine models have yielded promis-
ing results for tracking melanoma progression. (Gar-
eau et al., 2007; Li et al., 2005). The two modes may 
one day be used clinically in tandem. 
Instrumentation
Near-infrared CSLM was approved as an investiga-
tional tool in September 2008 by the Food and Drug 
Administration for human use (http://www.fda.gov/
cdrh/pdf8/K080788.pdf ).
Laser with an illumination power of 1 to 5 mW 
(low power lasers less than 40 mW), is safe on the 
tissue and causes no eye injury (Branzan et al., 2007; 
Gonzalez  and  Gilaberte-Calzada,  2008;  Nehal  et 
al., 2008). The original confocal microscope dem-
onstrated feasibility but was a large and immobile 
bench-top  instrument  that  made  imaging  human 
skin relatively difficult. A partnership between Lu-
cid Inc (Rochester, NY) and Massachusetts General 
Hospital led to the development of a smaller port-
able unit with an improved microscope-to-human 
skin interface. The first commercial confocal laser 
microscope was the Vivascope® 1000, and this model 
cannot be conveniently placed on certain anatomi-
cal areas (ear, medial canthus, intertriginous areas), 
(Busam et al., 2002). Currently, commercially avail-
able confocal laser microscope models are the Viva-
scope® 1500, a multilaser that combines reflectance 
with fluorescent confocal laser scanning microscopy; 
the Vivascope® 3000-handheld (Lucid, Inc., Henri-
etta, NY, USA), and OptiscanTM (Optiscan PVT Ltd, 
Australia). (Branzan et al., 2007, Patel et al., 2008). 
The  present  commercially  available  confocal  laser 
microscope uses a deeper penetrating near-infrared 
wavelength of 830 nm (diode laser) or wavelengths 
of 785 nm (near-infrared), 658 nm (red) or 445 nm 
(blue). Up to three lasers are integrated in one device 
(www.lucid-tech.com/imaging  Products.).  A  30X 
objective lens of NA 0.9 that is routinely used pro-
vides a field of view of 0.5 mm, lateral resolution of 
0.7 µm, and optical section thickness of 3 µm, which 
is  comparable  with  that  of  conventional  histology 
sections (Rajadhyaksha et al., 1995; Rajadhyaksha et 
al., 1999;). 
The maximum depth of imaging is 350 µm, de-
pendent on the examined tissue, with good visuali-
zation of the epidermis, papillary dermis, and upper 
reticular dermis. To enable visualization of larger ar-
eas of tissue with varying magnification, similar to 
that in histopathology, a two-dimensional sequence 
of images is captured and software-stitched into a 
mosaic of contiguous 500 x 500 µm images (Nehal et 
al., 2008). This mosaic represents an overview image 
with 5-fold magnification. The imaging procedure 
for  one  single  lesion  requires  approximately  5-15 
minutes (Hofmann-Wellenhof et al., 2009). Live im-
ages may be captured either as single frames or as 
sequential frames to form videos to demonstrate dy-
namic events (Nehal et al., 2008).
Confocal scanning laser microscopy features  
of normal skin
CSLM imaging of human skin in vivo has shown 
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jadhyaksha et al., 1995; Rajadhyaksha et al., 1999; 
Huzaira  et  al.,  2001).  When  imaging  the  skin  in 
real time, starting from the surface and progressing 
deeper, most superficial images are obtained from 
the stratum corneum. The structures are well visual-
ized in all stratums. The epidermis/dermis boundary 
seems to provide more information than other layers 
(Gerger et al., 2004). Some of the main characteris-
tics of CSLM features of normal skin are presented 
in Table 1.
Confocal scanning laser microscopy features of 
melanocytic skin lesions
Differential CSLM diagnosis of melanocytic lesions 
requires  analysis  of  the  architectural  and  cellular 
aspects of the skin, including melanocyte and ke-
ratinocyte shape and distribution. (Pellacani et al., 
2005). Because melanin provides a strong contrast in 
RCM, melanocytes can be easily assessed, enabling 
enhanced diagnosis and differentiation of malignant 
from benign melanocytic lesions, detection of local 
recurrences after surgical excision, and in vivo tu-
mor follow-up (Curiel-Lewandrowski et al., 2004). 
The first study to systematically investigate the use of 
in vivo CSLM in diagnosing pigmented skin lesions 
(PSLs), was that of Langley et al. in 2001 (Langley et 
al., 2001). Busam et al. described the morphological 
features  of  melanocytes,  pigmented  keratinocytes, 
and  melanophages  in  vivo  (Busam  et  al.,  2001a). 
CSLM  enables  the  recognition  and  position  of 
melanocytes within the epidermis. Therefore, it may 
allow immediate recognition of a pigmented lesion 
as melanocytic in origin. Once the melanocytes are 
recognized, the ability to analyze their growth pat-
tern within the epidermis should in principle allow 
a preliminary diagnostic evaluation and a decision 
on the need for a biopsy or excision (Busam et al., 
2001a).
Reflectance confocal microscopy features  
of melanoma
Pigmented  and  amelanotic  melanomas  exhibit  re-
markably  similar  features  when  assessed  by  RCM 
(Langley et al., 2001; Busam et al., 2001b; Curiel-
Lewandrowski  et  al.,  2004;  Tannous  et  al.,  2002). 
These features may be evident because of the pres-
ence of melanosomes or melanin-filled premelano-
somes in the cytoplasm (Hofmann-Wellenhof et al., 
2009). Another useful advantage of RCM is that it 
enables  the  noninvasive  detection  of  amelanotic 
melanoma (Busam et al., 2001b). RCM allows for the 
recognition of abnormal intraepidermal melanocytic 
proliferation in clinically amelanotic melanoma that 
is distinct from features of normal skin. 
A useful advantage of RCM is that it enables the 
identification of abnormal intraepidermal melano-
cytic  proliferation,  granules  and  dendritic  struc-
tures  in  clinically  amelanotic  melanomas.  This  is 
the  most  important  advantage  over  dermoscopy, 
since dermoscopy cannot provide the diagnosis of 
amelanotic melanoma with that level of certainty. In-
traepidermal melanoma (in situ) can be recognized 
by  CSLM  through  analysis  of  the  intraepidermal 
growth patterns of melanocytes using the same cri-
teria as established for conventional histology. The 
intraepidermal melanoma component shows atypi-
cal epithelioid melanocytes at all layers within the 
epidermis distributed in a pagetoid fashion as well as 
intraepidermal melanocytic nests with discohesion 
of cells (Busam et al., 2002; Pellacani et al., 2005). 
These include structural changes in the spinous and 
granular  layers,  keratinocyte  disarrangement  and 
loss of intercellular demarcation (disruption of the 
“honeycomb pattern”). Enlarged atypical cells with 
pleomorphic morphology, variable refractivity and 
angular nuclei may be found in several layers of the 
epidermis (pagetoid dissemination) (Langley et al., 
2001). Recognition of early melanoma in situ is also 
a very important advantage over dermoscopy. 
It needs to be borne in mind that this is not suf-
ficient for the diagnosis of melanoma. This feature 
can be seen in acral, congenital and Spitz nevi, as 
well as in recurrent nevi or after trauma (Weedon, 
1997; Cochran et al., 1997). Especially inflamed nevi, 
such as a nevus with associated eczematous features, 
may show an increased number of intraepidermal 
Langerhans  cells  simulating  pagetoid  melanocyto-
sis (Busam et al., 2005). On the other hand, regular 284 MILICA APOSTOLOVIĆ STOJANOVIĆ ET AL.
dermoepidermal  architecture,  and  the  absence  of 
pagetoid infiltration and atypical cells are suggestive 
of benign lesions. At the dermoepidermal junction 
level, non-edged papillae were observed in 90% of 
melanomas and in 41% of nevi, whereas edged pa-
pillae were predominantly present in nevi. Study has 
highlighted the importance of the identification of 
pagetoid infiltration that resulted the most relevant 
discriminating parameter (Pellacani et al., 2007).
Confocal imaging for tumor margin mapping
In vivo CSLM (‘‘virtual biopsies’’) has the potential 
to  guide  invasive  sampling  of  complex  cutaneous 
neoplasms, and promises to be useful for mapping 
the margins of a skin lesion prior to and during sur-
gical procedure. RCM may improve the presurgical 
and intraoperative margin detection for cutaneous 
neoplasms with ill-defined borders. This may help 
in the early detection of clinically barely visible or 
nonpigmented  melanomas,  as  well  as  lentigo  ma-
ligna  melanoma,  and  may  facilitate  preoperative 
noninvasive assessment of their margins (Busam et 
al., 2001b). Confocal imaging may also potentially be 
used for intraoperative assessment of the deep mar-
gins of resection during Mohs microscopically con-
trolled surgery (Rajadhyaksha et al., 2001; Chung et 
al., 2004).
Sensitivity and specificity CSLM in diagnosing 
melanocytic tumors
Studies have shown the high sensitivity and specifici-
ty for detecting melanocytic skin tumors with in vivo 
confocal imaging (Busam et al., 2001a; Langley et al., 
2001; Gerger et al., 2004; Gerger et al., 2005; Pellacani 
et al., 2005; Gerger et al., 2008a; Gerger et al., 2009). 
The diagnostic applicability of RCM in melanocytic 
skin  tumors,  determined  by  evaluating  sensitivity, 
specificity, as well as positive and negative-predictive 
value  (PPV,  NPV),  has  been  described  in  several 
studies (Busam et al., 2001a; Langley et al., 2001; 
Gerger et al., 2005; Pellacani et al., 2007; Langley  et 
al., 2008; Gerger et al., 2008b) (Table 2). Taking into 
account all RCM studies dealing with the diagnostic 
accuracy in melanocytic skin lesions, sensitivity and 
specificity of approximately 90% and 86%, respec-
tively, could be reached (Hofmann-Wellenhof et al., 
2009).
Advantages of confocal scanning laser microscopy
The main advantage of CLSM is the offer of a unique 
opportunity to image thin sections of living tissue 
at a resolution equal to that of conventional mi-
croscopes used to view histological slides. Cellular 
and architectural details can be examined without 
Table 1. The layers of the epidermis - main characteristics of CSlM* features of normal skin
Skin layer
Depth from
stratum corneum
(μm)
Keratinocyte
diameter
(μm)
Appearance
Stratum corneum Skin surface 15–30
Bright polygonal cells with dark outlines forming islands
separated by wrinkles (dermatoglyphs)
Stratum granulosum 15–20 20–35 Bright granular cytoplasm and dark oval or round nuclei
“honeycomb pattern“ or “cobblestone pattern“
Stratum spinosum 15–25 20–100
Similar pattern to the stratum granulosum but smaller cells with 
less refractive cytoplasm
Stratum basale 7–12 50–100
Highly refractive basal cells arranged as aggregates (horisontal 
optical sectioning at the suprapapapillary plates) or form bright 
rings (“edged papillae“) that increase in size at deeper levels 
(horisontal optical sectioning through the dermal papillae)
*CSLM - Confocal scanning laser microscopyCONFOCAL MICROSCOPY IN THE DIAGNOSIS OF MELANOMA 285
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having to excise and process the tissue as is done 
in standard histology. The whole procedure can be 
done in a few minutes ‘‘at the bedside’’. The cur-
rent commercially available technology is already 
advancing toward handheld confocal microscopes 
that are less expensive, less robust and easier to use 
on humans. In addition, CSLM’s features are easy 
to learn and use. Reflectance confocal microscopy, 
similar to dermoscopy, images lesions in an en face 
plane, thus enabling direct correlations with der-
moscopic images.
Consequently, the RCM can provide subsampling 
of the region of interest on the dermoscopic image; 
pointing the cursor at a dermoscopic structure on the 
digital image will focus the RCM to scan the corre-
sponding location (Scope et al., 2007). Such a direct 
comparison between the two techniques could be 
achieved by selecting lesions by naked-eye examina-
tion and then applying both methods. However, the 
RCM specificity was more than two-fold superior to 
dermoscopy for light-colored lesions. The improved 
diagnostic accuracy of RCM with light-colored le-
sions may be explained by the fact that melanin ap-
pears very bright under reflectance microscopy, even 
in very small quantities. CSLM had a relatively higher 
sensitivity over dermoscopy with similar specificity. 
These results suggest that dermoscopy and CSLM are 
complementary (Langley et al., 2008). Confocal mi-
croscopy seems useful for second-level examination 
of clinically and dermoscopically equivocal lesions 
(Guitera et al., 2009).
Limitations of CSLM
A limitation in the current state of RCM technol-
ogy is that the imaging is restricted to a depth of 
350-500 µm due to tissue-induced scattering and 
aberrations,  which  corresponds  to  the  papillary 
dermis and, depending on skin thickness, the su-
perficial reticular dermis. Therefore, assessment of 
microanatomical structures in the reticular dermis 
or tumor invasion depth cannot be evaluated reli-
ably. The presence of refractive structures may also 
decrease contrast and make melanocyte visualiza-
tion  difficult.  This  might  be  improved  by  testing 
the  different  immersion  media  and  illumination 
sources  (Hofmann-Wellenhof  et  al.,  2009).  The 
grayscale (black/white) contrast also lacks specifi-
city for organelles and ultrastructure (Nehal et al., 
2008). Nuclear features (e.g. mitoses) cannot be as-
sessed accurately by CSLM (Branzan et al., 2007). 
Recently, novel confocal line-scanning microscopes 
have demonstrated the imaging of nuclear and cel-
lular morphology in human epidermis. Multimodal 
confocal microscopy and spectrally encoded con-
focal microscopy (SECM) may thus offer enhanced 
diagnostic  potential  and  application  (Boudoux 
et al., 2005). As 5-10 minutes are required for the 
CLSM diagnosis of a single lesion, the method is 
clearly not to be applied for the first-level examina-
tion (Guitera et al., 2009), but only after clinical and 
dermoscopic examination. 
CONCLUSION
CSLM represents an opportunity for the noninva-
sive evaluation of skin lesions in histological de-
tail. It may be employed as a guide for perform-
ing biopsies by helping to determine which areas 
have features suspect for malignancy and reducing 
sampling error, or as an adjunct to Mohs surgery 
and therapy by mapping out the margins or extent 
of involvement prior to excision or other thera-
pies. In addition, CSLM can be used to monitor 
the  progression  or  resolution  of  lesions,  provid-
ing for reduced number of unnecessary biopsies. 
In the future, CSLM might be used as an in vivo 
follow-up  of  the  natural  changes  in  melanocyte 
nevi due to aging or sun exposure, as already es-
tablished with digital dermoscopy (Dobrosavljevic 
et al., 2009). Although it is currently too expensive 
and laborious to be considered as a screening tool 
for  melanoma,  with  minor  advances  CSLM  may 
become practical for assessing pigmented lesions 
that have been selected as suspect on the basis of 
clinical examination and/or dermoscopy (Busam 
et al., 2005).
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